The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): NIL
Expected first date of trading: 29/04/2014
Market: AIM
Location of address at which admission document will be available: http://www.bioventix.com/investors.htm The Admission Document will contain full details about the Company and the admission of its securities.
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): finnCap Ltd
Nominated Broker (AIM Companies): finnCap Ltd

Company details
Name Role
Ian James Nicholson Non-Executive Chairman
Peter John Harrison Chief Executive Officer
Treena Joan Turner Non-Executive Finance Director
Nicholas (Nick) John McCooke Non-Executive Director

Facts and Figures
Fiscal year end: 30 June
Incorporated in: England & Wales
Website URL: http://www.bioventix.com/investors.htm
space
Description of business:
Bioventix is a company incorporated in England & Wales which creates and supplies monoclonal antibodies to companies that manufacture blood testing machines.

Person(s) interested:
Before and After Admission: Significant Shareholders % Henderson Global Investors Ltd 27.5% Miton Group plc 22.6% Peter John Harrison 16.7% ISIS Equity Partners LLP 7.6% Hargreave Hale Limited 4.9%


Bioventix plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds